首页> 外文期刊>Acta clinica Croatica >THE ROLE OF TILT-TABLE TEST IN DIFFERENTIAL DIAGNOSIS OF UNEXPLAINED SYNCOPE
【24h】

THE ROLE OF TILT-TABLE TEST IN DIFFERENTIAL DIAGNOSIS OF UNEXPLAINED SYNCOPE

机译:倾斜台试验在不明原因同步诊断中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this retrospective study (February 2012 September 2014) was to assess the role of head-up tilt-table test in patients with unexplained syncope. It was performed on 235 patients at Clinical Department of Cardiology, Sestre milosrdnice University Hospital Center. Patients were classified according to test indications: group A (convulsive syncope, n=30), group B (suspected vasovagal syncope, n=180), and group C (paroxysmal vertigo, n=25). The groups were analyzed and compared according to demographic data (age and gender), referral specialist (cardiologist, neurologist, and others), and test results (positiveegative) with specific response (cardioinhibitory, vasodepressor, or mixed). Groups A and B were referred most frequently by neurologists and cardiologists (p<0.05). The test was positive in 34 (14.5%) of all evaluated patients (5 in group A and 29 in group B), of which 13 (38.2%) had cardioinhibitory, 11 (32.4%) mixed and 10 (29.4%) vasodepressor response. In the cardioinhibitory subgroup, three patients (23.1%, 2 males/1 female, mean age 28.5 years) with normal electroencephalography were on antiepileptics. During head up tilt-table testing, they had bradycardia (heart rate 30.0 +/- 5.0 beats/min) and prolonged asystole (13.7 +/- 11.0 seconds) with development of typical convulsions. These three subjects got a permanent pacemaker (atrial/ventricular stimulation, heart rate control) and anticonvulsive therapy was slowly withdrawn with no syncope recurrence during 24-month follow up. In conclusion, head-up tilt-table test has an important role in the evaluation of patients with unexplained syncope and in differential diagnosis of vasovagal syncope. The indication for pacemaker implantation, strictly following the European Society of Cardiology guidelines, proved to be effective in preventing syncope relapses in patients with cardioinhibitory convulsive syncope.
机译:这项回顾性研究(2012年2月,2014年9月)的目的是评估抬头式倾斜台试验在原因不明的晕厥患者中的作用。在Sestre milosrdnice大学医院中心的心脏病学临床科对235位患者进行了此项检查。根据测试指征对患者进行分类:A组(惊厥性晕厥,n = 30),B组(疑似血管迷走性晕厥,n = 180)和C组(阵发性眩晕,n = 25)。根据人口统计学数据(年龄和性别),转诊专家(心脏病专家,神经科医生等)和测试结果(阳性/阴性)对这些组进行分析和比较,并得出特定的反应(抑制性,抗血管生成素或混合性)。 A组和B组被神经科医师和心脏病专家最频繁转诊(p <0.05)。在所有评估的患者中,有34例(14.5%)(A组5例,B组29例)呈阳性反应,其中13例(38.2%)具有心脏抑制作用,11例(32.4%)具有心脏抑制作用,而10例(29.4%)具有血管抑制作用。在心脏抑制亚组中,三例脑电图正常的患者(23.1%,2例男性/ 1例女性,平均年龄28.5岁)接受了抗癫痫治疗。在抬头式倾斜台测试中,他们出现心动过缓(心率30.0 +/- 5.0拍/分钟),并出现典型的惊厥,并出现了延长的心搏停止(13.7 +/- 11.0秒)。这三名受试者均获得永久性起搏器(心房/心室刺激,心率控制),并且在24个月的随访中缓慢撤回抗惊厥疗法,无晕厥复发。总之,抬头倾斜台试验在评估原因不明的晕厥和鉴别血管迷走性晕厥中具有重要作用。严格遵循欧洲心脏病学会指南,心脏起搏器植入的适应症可有效预防心脏抑制性惊厥性晕厥患者的晕厥复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号